Present byJshosseini Anatomy Retroperitoneal Organ Weighs 75 To 100 G 15 To 20 Cm Long Head Neck Body Tail 2 Inflammation or infection of the pancreas Normally digestive enzymes secreted by the pancreas are not ID: 930707
Download Presentation The PPT/PDF document "Acute & Chronic Pancreatitis" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Acute & Chronic
Pancreatitis
Present
by:J.s.hosseini
Slide2AnatomyRetroperitoneal Organ Weighs 75 To 100 G 15 To 20 Cm LongHeadNeckBodyTail 2
Slide3Inflammation or infection of the pancreas Normally digestive enzymes secreted by the pancreas are not active until they reach the SI. When the pancreas is inflamed, the enzymes attack and .damages the tissue that produce them2 types: 1. Acute Pancreatitis 2. Chronic Pancreatitis 3
What is Pancreatitis?
Slide4Acute Pancreatitis4
Slide5Definition and Incidence Inflammatory disease with little or no fibrosis. Initiated by several factors: 90% of acute pancreatitis is secondary to acute cholelithiasis or ETOH abuse Develop additional complications 300,000 cases occur in the united states each year leading to over 3000 deaths.5
Slide6Etiology: (GET SMASHED)G: GallstoneE: Ethanol T: TraumaS: SteroidM: MumpA :AutoimmuneS: Scorpion bitsH: HyperlipidemiaE: ERCPD: Drugs
6
Slide7Clinical PresentationAbdominal painEpigastricRadiates to the backWorse in supine positionNausea and vomitingGardingTachycardia, Tachypnea, Hypotension, HyperthermiaElevated Hematocrit & Pre renal azotemiaCullen's signGrey Turner's sign7
Slide8Grey Turner sign
Cullen’s sign
8
Slide9Diagnosis: Biochemical serum amylase Nonspecific Returns to normal in 3-5 days Normal amylase does not exclude pancreatitis Level of elevation does not predict disease severity Urinary amylase P-amylaseSerum Lipase CBC Increased HbThrombocytosisLeukocytosis
Liver
Function Test
Serum Bilirubin elevated
Alkaline
Phosphatase
elevated
Aspartate
Aminotransferase elevated
9
Slide10Assessment of SeverityCriteria 1.ranson2.APACHE-2Biochemical MarkersComputed Tomography Scan10
Slide11Ranson CriteriaCriteria for acute gallstone pancreatitisAdmissionAge > 70WBC > 18,000Glucose > 220LDH > 400AST > 250During first 48 hoursHematocrit drop > 10 pointsSerum calcium < 8Base deficit >
5.0
Increase in BUN >
2
Fluid sequestration >
4L
11
<2
pos
sign: mortality rate is 0
3-5
pos
sign: mortality rate
is
10 to 20
%
>7
pos
sign: mortality rate is
>
50%
Slide12CT scans of normal kidneys and pancreasSpleen
L Kidney
R Kidney
A
Stomach
Liver
V
Pancreas
12
Slide13Pancreatic Necrosis13
Slide14Treatmaent of Mild PancreatitisPancreatic restSupportive carefluid resuscitation – watch BP and urine outputPain ControlNG tubes and H2 blockers or PPIs are usually not helpfulRefeeding (usually 3 to 7 days) If:Bowel Sounds PresentPatient Is HungryNearly Pain-free (Off IV Narcotics)Amylase & Lipase Not Very Useful14
Slide15Treatment of Severe PancreatitisPancreatic Rest & Supportive CareFluid Resuscitation – may require 5-10 liters/dayCareful Pulmonary & Renal Monitoring – ICUMaintain Hematocrit Of 26-30%Pain Control – PCA pumpCorrect Electrolyte Derangements (K+, Ca++, Mg++)Contrasted CT scan at 48-72 hoursProphylactic antibiotics if presentNutritional supportMay be NPO for weeksTPN
15
Slide16ComplicationsLocal Phlegmon, Abscess, Pseudocyst, AscitesInvolvement of adjacent organs, with hemorrhage, thrombosis, bowel infarction, obstructive jaundice, fistula formation, or mechanical obstruction Systemic A. Pulmonary: pleural effusions, atelectasis, hypoxemia, ARDS.B. Cardiovascular: myocardial depression, hemorrhage, hypovolemia.C.Metabolic
:
Hypocalcemia,hyperglycemia,Hyperlipidemia,coagulopathy
D. GI Hemorrhage
E
.
Renal
F
.
Hematologic
G
.
CNS
H
. Fat
necrosis
16
Slide17Management17
Slide18Chronic Pancreatitis18
Slide19Definition and PrevalenceDefined as chronic inflammatory condition that causes irreversible damage to pancreatic structure and function.Incurable5 To 27 Persons Per 100,000 19
Slide20EtiologyAlcohol, 70% Idiopathic (including tropical), 20% Other, 10% Hereditary Hyperparathyroidism Hypertriglyceridemia Autoimmune pancreatitis Obstruction Trauma Pancreas divisum20
Slide21Classification:1. calcific pancreatitis2. obstraction pancreatitis3. inflammatory pancreatitis4. auto immune pancreatitis5. asymptomic fibrosis6. tropical pancreatitis7. hereditary pancreatitis8. idiopathic pancreatitis 21
Slide22Signs and SymptomsSteady And Boring PainNot ColickyNausea Or Vomiting Anorexia Is The Most Common Malabsorption And Weight LossApancreatic Diabetes22
Slide23Laboratory StudiesTests for Chronic PancreatitisI. Measurement of pancreatic products in blood A. Enzymes B. Pancreatic polypeptide
II. Measurement of pancreatic exocrine secretion
A
. Direct measurements
1
. Enzymes
2
. Bicarbonate
B
. Indirect measurement
1
.
Bentiromide
test
2
. Schilling test
3
. Fecal fat, chymotrypsin, or
elastase
concentration
4
. [
14
C]-
olein
absorption
III. Imaging techniques
A
. Plain film radiography of abdomen
B
. Ultrasonography
C. Computed tomography
D. Endoscopic retrograde cholangiopancreatography
E. Magnetic resonance cholangiopancreatography
F. Endoscopic ultrasonography
23
Slide2424Pancreatic calcifications. CT scan showing multiple, calcified, intraductal stones in a patient with hereditary chronic pancreatitisEndoscopic retrograde cholangiopancreatography in chronic pancreatitis. The pancreatic duct and its side branches are irregularly dilated
Slide25CT features 25The cardinal CT features of CP are pancreatic atrophy, calcifications, and main pancreatic duct dilation .
Slide26ERCP26ERCP is a highly sensitive radiographic test for CP.
Slide27MRCP27MRCP allows a noninvasive alternative to ERCP for imaging the pancreatic duct.
Slide28EUSEUS is a minimally invasive test that allows simultaneous assessment of ductal and parenchymal structure. 28
Slide29TreatmentAnalgesiaEnzyme TherapyAntisecretory TherapyNeurolytic TherapyEndoscopic ManagementSurgical Therapy29
Slide30ComplicationsPseudocystPancreatic AscitesPancreatic-Enteric FistulaHead-of-Pancreas MassSplenic and Portal Vein Thrombosis30
Slide3131
Slide32Management32
Slide3333